2,181 results match your criteria Mitral Valvuloplasty


Percutaneous mitral commissurotomy in women with asymptomatic severe mitral stenosis before pregnancy.

Acta Cardiol 2020 Jun 29:1-6. Epub 2020 Jun 29.

Department of Cardiology, Yüzüncü Yıl University, Van, Turkey.

Performing percutaneous mitral commissurotomy (PMC) in the women with asymptomatic severe mitral stenosis (MS) who plan a pregnancy is recommended. However the data regarding this recommendation is limited in the literature. We aimed to investigate maternal and fetal outcomes of women with asymptomatic severe MS who underwent PMC before a planned pregnancy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00015385.2020.1783778DOI Listing

Fetal aortic valvuloplasty: first report of two cases from Saudi Arabia.

J Cardiothorac Surg 2020 Jun 22;15(1):150. Epub 2020 Jun 22.

Pediatric Cardiology Department, Prince Sultan Cardiac Center, Prince Sultan Military Medical City, As Sulimaniyah, Riyadh, 12233, Saudi Arabia.

Background: Fetal aortic stenosis may progress to hypoplastic left heart syndrome (HLHS), which carries a poor prognosis. We report two infants with fetal aortic stenosis successfully treated with fetal aortic valvuloplasty (FAV) using balloon dilatation.

Case Presentation: Of five fetuses with aortic stenosis fulfilling the FAV criteria of severe aortic stenosis with a left ventricular length Z-score of ≥ - 2, retrograde flow in the transverse aortic arch, left-to-right flow across the foramen ovale, monophasic mitral inflow, and significant left ventricular dysfunction, we obtained permission for FAV in two fetuses. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13019-020-01195-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310221PMC

Fusion imaging during balloon mitral valvulopasty: First experience.

Echocardiography 2020 Jun 12. Epub 2020 Jun 12.

Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA.

The EchoNavigator (EchoNav, Philips, The Netherlands) is a tool that fuses live X-ray with three-dimensional (3D) transesophageal echocardiogram (TEE) images allowing for enhanced precision and accuracy during interventional cardiac procedures. We present the first case of EchoNav utilization during balloon mitral valvuloplasty using the newest version (EchoNav 3.0. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/echo.14753DOI Listing
June 2020
1.254 Impact Factor

Asymmetric Calcification in Rheumatic Mitral Stenosis and Implications for Balloon Valvuloplasty.

JACC Case Rep 2019 Dec 18;1(4):493-494. Epub 2019 Dec 18.

Section of Cardiology, Department of Medicine, University of Chicago Medical Center, Chicago, IL.

A 50 year-old male with severe rheumatic mitral stenosis was deemed too high risk for surgery and referred for percutaneous balloon valvuloplasty. The valvuloplasty was successful in reducing the trans-mitral gradient and improving the patient's symptoms, however was complicated by a tear in the posteromedial commissure and moderate mitral regurgitation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaccas.2019.10.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277047PMC
December 2019

First-in-Human Study of the Saranas Early Bird Bleed Monitoring System for the Detection of Endovascular Procedure-Related Bleeding Events.

J Invasive Cardiol 2020 Jul 8;32(7):255-261. Epub 2020 Jun 8.

Gagnon Cardiovascular Institute, Morristown Medical Center, 100 Madison Avenue, Morristown, NJ 07960 USA.

Objectives: To evaluate the safety and accuracy of the Early Bird Bleed Monitoring System (EBBMS; Saranas) for the detection of access-site related bleeds in humans undergoing endovascular procedures.

Background: Bleeding complications after endovascular procedures are frequent and associated with poor prognosis. The EBBMS is a novel technology designed to detect in real time the onset, progression, and severity of internal bleeds. Read More

View Article

Download full-text PDF

Source
July 2020
0.824 Impact Factor

Diagnosis and treatment of infective endocarditis in pregnancy: a case report.

J Cardiothorac Surg 2020 May 24;15(1):109. Epub 2020 May 24.

Department of Ultrasound, Zhejiang Provincial People's Hospital, People's Hospital of HangZhou Medical College, Hangzhou, 310014, Zhejiang, China.

Background: Pregnancy with infective endocarditis (IE) is rare, but the fetal and maternal mortality rates of these pregnancies are very high, making IE a serious threat to the safety of pregnant women and their fetuses. Therefore, for pregnant women with recurrent fever, a detailed medical history and physical examination should be performed, echocardiography and blood culture should be carried out as soon as possible, multidisciplinary consultation should be implemented, and a diagnosis and treatment plan should be formulated right away, as this is key to saving the lives of mothers and infants.

Case Introduction: A 30-year-old pregnant Chinese woman had IE at 26 weeks of gestation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13019-020-01147-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245794PMC
May 2020
1.018 Impact Factor

[Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis with Preexisting Mitral Prosthesis;Report of a Case].

Kyobu Geka 2020 Mar;73(3):223-226

Department of Cardiovascular Surgery, Iwaki City Medical Center, Iwaki, Japan.

An 81-year-old woman presented with progressive congestive heart failure. Seventeen years before, she had undergone mitral valve replacement with a mechanical prosthesis. Echocardiography revealed severe aortic stenosis with a depressed left ventricular ejection fraction of 32%. Read More

View Article

Download full-text PDF

Source

Massive hemoptysis in a pregnant woman: the first rare presentation of mitral valve stenosis.

Monaldi Arch Chest Dis 2020 May 11;90(2). Epub 2020 May 11.

School of Medicine, Mashhad University of Medical Sciences, Mashhad.

Massive hemoptysis is one of the rare manifestations of mitral valve stenosis. Massive hemoptysis is considered as a potentially life threatening that frequently needs emergency procedures. A 43- year-old pregnant woman presented with coughing and massive hemoptysis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4081/monaldi.2020.1200DOI Listing

Acute fulminant hemolysis after transcatheter mitral valve replacement for mitral annular calcification.

Catheter Cardiovasc Interv 2020 May 6. Epub 2020 May 6.

Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.

Transcatheter mitral valve replacement (TMVR) is emerging as an alternative treatment strategy to surgery for patients with severe mitral annular calcification (MAC) who are not candidates for traditional mitral valve surgery. Paravalvular leak (PVL) is common following TMVR for severe MAC and can lead to heart failure symptoms and/or intravascular hemolysis, the latter of which usually is clinically stable. We report the case of a 67-year-old woman with symptomatic severe aortic stenosis and mitral stenosis with MAC in the setting of prior chest irradiation who was treated initially with transcatheter aortic valve replacement followed by TMVR at a later date (Sapien S3 system; Edwards Lifesciences). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28944DOI Listing

Antegrade transseptal transcatheter aortic valve replacement: Back to the future?

Catheter Cardiovasc Interv 2020 Apr 30. Epub 2020 Apr 30.

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Antegrade transseptal approach was utilized in the first human case of transcatheter aortic valve replacement (TAVR) and in the early phase of TAVR. Various challenges with the antegrade transseptal approach including procedural complexity, need for atrial septal crossing, and potential for injury to the mitral valve apparatus led it to being supplanted by other approaches. These challenges have now largely been mitigated as structural interventionalists routinely perform left atrial procedures. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28934DOI Listing

Impact of balloon mitral valvuloplasty on left ventricular rotational deformation: Magnetic Resonance Imaging follow up study.

Int J Cardiovasc Imaging 2020 Apr 23. Epub 2020 Apr 23.

Department of Cardiothoracic Surgery, Aswan Heart Centre, Aswan, Egypt.

In patients with rheumatic mitral stenosis (MS), some previous studies have investigated the influence of balloon mitral valvuloplasty (BMV) on left ventricular (LV) systolic function. However, the impact of BMV on LV twisting motion in this clinical setting has not been studied before yet. To describe changes in LV torsion in patients with rheumatic MS following BMV. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10554-020-01856-yDOI Listing

TEG improves anticoagulation management during cardiopulmonary bypass complicated by antiphospholipid syndrome.

J Card Surg 2020 Jun 17;35(6):1354-1356. Epub 2020 Apr 17.

Department of Cardiovascular Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Background And Aim: Cardiopulmonary bypass (CPB) in antiphospholipid syndrome (APS) patients carries a high risk of thrombosis and hemorrhage. However, optimal anticoagulation surveillance methods have not been established and heparin optimization has not yet been totally validated as reflective of anticoagulation status.

Methods And Result: Here, a 45-year-old female with APS underwent mitral valvuloplasty due to infective endocarditis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jocs.14557DOI Listing

Mid-term effect of balloon aortic valvuloplasty on mitral regurgitation in aortic stenosis.

Cardiovasc Ultrasound 2020 Apr 13;18(1):10. Epub 2020 Apr 13.

Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.

Background: Balloon aortic valvuloplasty (BAV) offers an alternative to conventional aortic valve replacement in elderly and frail patients with severe aortic stenosis (AS) for whom there are no other effective options. We aimed to investigate the mid-term effect of BAV on mitral regurgitation (MR) in patients with severe AS.

Methods: Our analysis was based on the data from 83 patients with severe AS (mean age, 86 ± 5 years; female, 68) treated using BAV. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12947-020-00193-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155284PMC

When Prosthetic Valves Compete for Space: A Case of Transcatheter Aortic Valve Embolization Due to Prosthetic Mitral Valve.

Cureus 2019 Mar 22;11(3):e4299. Epub 2019 Mar 22.

Interventional Cardiology, Mount Sinai Medical Center, Miami Beach, USA.

Transcatheter aortic valve replacement (TAVR) is now the preferred choice of treatment for severe symptomatic aortic stenosis (AS) patients who are at intermediate to high risk for surgery. Rare complications like valve embolization have been described and we report a case with unique cause for such complication. A 79-year-old female presented with new onset dyspnea on exertion for evaluation and work up to the outside hospital and was found to have severe AS and referred to us for TAVR evaluation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7759/cureus.4299DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055012PMC

Mitral and tricuspid stenosis caused by light chain cardiac amyloid deposition.

ESC Heart Fail 2020 Jun 16;7(3):1130-1135. Epub 2020 Mar 16.

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, 44195, USA.

Cardiac amyloidosis results in an infiltrative restrictive cardiomyopathy, with a number of characteristic features: biventricular hypertrophy, abnormal myocardial global longitudinal strain with relative apical sparing, biatrial dilation, and small pericardial effusion along with conduction abnormalities. Amyloid deposits leading to hemodynamically significant valvular heart disease are very rare. We describe a rare case of concomitant moderately severe tricuspid and mitral valve stenosis because of ongoing amyloid deposition in a patient with progressive multiple myeloma and fat pad biopsy-proven light chain amyloidosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ehf2.12668DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261535PMC

Transvenous Transseptal Concurrent Inoue Balloon Mitral and Aortic Valvuloplasty in an Octogenarian With Severe Aortic and Mitral Stenosis.

CJC Open 2020 Jan 18;2(1):30-33. Epub 2019 Nov 18.

Cardiovascular Center, Taichung Veterans General Hospital, Taichung, Taiwan.

An octogenarian was admitted because of severe aortic stenosis (AS) and mitral stenosis. He declined surgical double-valve replacement and underwent intracardiac echocardiography-guided transseptal puncture and concurrent Inoue (Toray, Tokyo, Japan) balloon aortic valvuloplasty (BAV) and balloon mitral valvuloplasty (BMV). Nine months later, he had worsening pulmonary edema and received a second session of Inoue BAV and BMV. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cjco.2019.11.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063637PMC
January 2020

Ischemic mitral regurgitation: problem extent in cardiovascular surgery clinic.

Wiad Lek 2020 ;73(1):36-40

Amosov National Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine.

Objective: The aim of the study was to evaluate the prevalence, etiology, mechanisms and severety of all cases of MR, including IMR, in the patients population with suspected or proved CAD before coronary arteries evaluation and surgery or intervention.

Patients And Methods: Materials and methods: The study prospectively included 370 patients with verified or suspected (angina pectoris suspicion or manifested CHF) CAD of all clinical forms (stable, unstable, post-AMI, prior revascularization, etc.). Read More

View Article

Download full-text PDF

Source

Early outcomes of mitral valvuloplasty by minimally invasive surgery or sternotomy.

Asian Cardiovasc Thorac Ann 2020 Mar 2:218492320911756. Epub 2020 Mar 2.

Department of Cardiovascular Surgery, Guangdong Provincial Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Guangzhou, China.

Background: Disagreement exists regarding methods for repair of the mitral valve. We compared early outcomes of mitral valvuloplasty by a minimally invasive technique and by a median sternotomy.

Methods: The data of 507 patients (mean age 47. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0218492320911756DOI Listing

Interannular bridge: a novel approach to address congenital mitral regurgitation.

Ann Thorac Surg 2020 Feb 28. Epub 2020 Feb 28.

Department of Cardiovascular Surgery, Mt. Fuji Shizuoka Children's Hospital, Shizuoka City, Shizuoka, Japan.

A male infant with Kabuki syndrome was diagnosed with trivial congenital mitral regurgitation at birth. At the age of 2 years and 9 months, the regurgitation worsened from mild to severe; thus, expedited surgical treatment was pursued. The primary operative finding was severe dysplastic two-leaflet disease. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2020.01.036DOI Listing
February 2020

Evaluation of the Effect of Percutaneous Mitral Balloon Valvuloplasty on Left Ventricular Systolic Functions Using Strain and Strain Rate Echocardiograph.

Turk J Med Sci 2020 Feb 25. Epub 2020 Feb 25.

Background And Aim: This study aimed to evaluate the effect of successful percutaneous mitral balloon valvuloplasty (PMBV) on left ventricular systolic functions using strain and strain rate echocardiography in moderate-severe mitral stenosis (MS) patients with normal left ventricular systolic function confirmed by conventional echocardiography.

Materials And Methods: Patients with moderate-severe MS, who had undergone successful PMBV, were included. Conventional echocardiographic parameters were evaluated before and after PMBV. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3906/sag-1901-69DOI Listing
February 2020

A case of abdominal bleeding after mitral valvuloplasty assisted by da Vinci robotic surgery.

J Card Surg 2020 Mar 23;35(3):683-685. Epub 2020 Jan 23.

Department of Cardiovascular Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

A 66-year-old female patient was admitted with abdominal bleeding as an unexpected complication of robotic surgery. Assessments included the patient's medical history, physical examination, laboratory data, and abdominal ultrasound scan results. In our case, laparotomy revealed an injury to the diaphragm and liver of the patient caused by the previous robotic surgery. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jocs.14413DOI Listing

New-onset complete right bundle branch block following successful balloon mitral valvuloplasty for mitral stenosis: a new phenomenon?

BMJ Case Rep 2020 Jan 15;13(1). Epub 2020 Jan 15.

Cardiology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2019-232930DOI Listing
January 2020

Cardiac magnetic resonance imaging for assessment of mitral stenosis before and after percutaneous balloon valvuloplasty in comparison to two- and three-dimensional echocardiography.

Acta Radiol 2020 Jan 14:284185119897368. Epub 2020 Jan 14.

Department of Cardiovascular Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0284185119897368DOI Listing
January 2020

Gene-based anticoagulation regimens for an infant after mitral-valve replacement: A case report.

Medicine (Baltimore) 2020 Jan;99(2):e18651

Department of Pharmacy, Fujian Medical University Union Hospital.

Rationale: Heart-valve replacement is one of the main surgical methods for various heart-valve diseases. Warfarin is the only oral anticoagulant used for thrombosis prevention after heart-valve replacement. However, warfarin has a narrow therapeutic window, large differences in efficacy between individuals, and can be affected by drugs, food and disease status. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000018651DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959923PMC
January 2020

Hybrid Minimally Invasive Approach for Combined Obstructive Coronary Artery Disease and Severe Aortic Stenosis.

Innovations (Phila) 2020 Mar/Apr;15(2):131-137. Epub 2020 Jan 1.

5945 Department of Cardiothoracic Surgery, Lenox Hill Heart and Lung, Northwell Health System, New York, NY, USA.

Objective: There is a high prevalence of concomitant coronary artery disease (CAD) and aortic stenosis (AS), and these conditions can be treated with a variety of invasive and/or percutaneous approaches. The aim of this study is to demonstrate the feasibility, efficacy, and safety of a staged transcatheter aortic valve replacement (TAVR) after a hybrid minimally invasive direct coronary artery bypass surgery (MIDCAB) to treat combined complex CAD and AS.

Methods: Six patients with concomitant CAD and severe AS underwent staged treatment of their CAD with MIDCAB and TAVR. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1556984519896581DOI Listing
January 2020

Mitral Valve Surgery in the First Year of Life.

Pediatr Cardiol 2020 Feb 21;41(2):334-340. Epub 2019 Dec 21.

Medical City Hospital, Dallas, TX, USA.

Data are limited on outcomes associated with mitral valve surgery in infants. Prior studies report high mortality and increased risk for late cardiac failure particularly for those with mitral stenosis. We sought to evaluate outcomes in patients with mitral stenosis (MS) or regurgitation (MR) who had mitral valvuloplasty or replacement in the first year of life. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00246-019-02262-5DOI Listing
February 2020

[The mid-term outcomes of minimally invasive plasty for severe tricuspid regurgitation after cardiac surgery].

Zhonghua Wai Ke Za Zhi 2019 Dec;57(12):902-907

Department of Cardiovascular Surgery, Guangdong Provincial Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Guangzhou 510100, China.

To evaluate the efficacy of minimally invasive surgery in patients with late severe tricuspid regurgitation after cardiac surgery, and to evaluate the role of leaflets augmentation technique in tricuspid valvuloplasty. From January 2015 to June 2019, 85 patients undergoing tricuspid valve repair procedure with minimally invasive approach at Department of Cardiovascular Surgery, Guangdong provincial People's Hospital were enrolled. There were 22 males and 63 females, aging of (53. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.0529-5815.2019.12.006DOI Listing
December 2019

Percutaneous Valve Interventions in the Adult Congenital Heart Disease Population: Emerging Technologies and Indications.

Can J Cardiol 2019 Dec 24;35(12):1740-1749. Epub 2019 Oct 24.

Toronto Congenital Cardiac Centre for Adults, Division of Cardiology, University of Toronto, Mount Sinai Hospital, University Health Network, Toronto, Ontario, Canada.

Adult survivors with congenital heart disease are not cured and residual cardiac valve lesions are common and contribute substantially to long-term morbidity. Given the increased risk of reoperations in patients with previous cardiac surgery, percutaneous treatment options have been developed. Initially percutaneous therapies focused on right ventricular outflow tract lesions, but they have now expanded to include mitral and aortic valve interventions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cjca.2019.10.019DOI Listing
December 2019

Reverse-Loop Technique for Percutaneous Transvenous Mitral Commissurotomy in a Patient With Huge Left Atrium.

J Invasive Cardiol 2019 Dec;31(12):E397

Department of Cardiology, Advanced Cardiac Centre, Post Graduate Institute of Medical Education & Research, Sector 12, Chandigarh - 160 012, India.

A 34-year-old man was referred for percutaneous transvenous mitral commissurotomy (PTMC); he had undergone 2 PTMC attempts at another institute, but both attempts failed because of inability to cross the mitral valve with the balloon. We present an alternative reverse-loop technique for PTMC in patients with large left atrium. Read More

View Article

Download full-text PDF

Source
December 2019

Strain imaging to assess early effects of successful percutaneous balloon mitral valvotomy on left atrium mechanics.

Egypt Heart J 2019 Nov 21;71(1):25. Epub 2019 Nov 21.

Department of Medicine, Kasturba Medical College Manipal, Manipal Academy of Higher Education (MAHE), Manipal, India.

Background: Global left atrial strain (LA) has been used as a novel assessment tool to evaluate left atrial function. However, not much has been investigated to study the effect of percutaneous balloon mitral valvotomy (BMV) in patients with rheumatic severe mitral stenosis on global LA strain. We studied the relationship between global left atrial (LA) strain and severe mitral stenosis and the effect of BMV on LA strain. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s43044-019-0021-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872685PMC
November 2019

MitraClip Deployed via Left Femoral Vein in an 85-Year-Old Woman with Mitral Regurgitation.

Tex Heart Inst J 2019 Jun 1;46(3):195-198. Epub 2019 Jun 1.

The MitraClip system can be used to control regurgitant blood flow in patients with mitral regurgitation who cannot tolerate open surgery to replace the mitral valve. Technical limitations make the right femoral vein the standard access point for placing the MitraClip. However, this route is not always suitable. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14503/THIJ-17-6546DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827463PMC

Additive value of 3D-echo in prediction of immediate outcome after percutaneous balloon mitral valvuloplasty.

Egypt Heart J 2019 Sep 18;71(1):19. Epub 2019 Sep 18.

Cardiology Department, Faculty of Medicine, Minia University, Minya, 61111, Egypt.

Background: Results of percutaneous balloon mitral valvuloplasty (BMV) are basically dependent on suitable patient selection. Currently used two-dimensional (2D) echocardiography (2DE) scores have many limitations. Three-dimensional (3D) echocardiography (3DE)-based scores were developed for better patient selection and outcome prediction. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s43044-019-0019-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821434PMC
September 2019

Percutaneous balloon mitral valvuloplasty: is there still a place for it in the Netherlands?

Authors:
P den Heijer

Neth Heart J 2019 Nov;27(11):537-540

Heart Center, Amphia Hospital, Breda, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12471-019-01343-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823546PMC
November 2019

Fetal Cardiac Intervention in Critical Aortic Stenosis with Severe Mitral Regurgitation, Severe Left Atrial Enlargement, and Restrictive Foramen Ovale.

Fetal Diagn Ther 2020 8;47(5):440-447. Epub 2019 Oct 8.

Division of Prenatal Medicine and Gynecologic Sonography, University of Cologne, Cologne, Germany.

Objective: To assess the intrauterine course and outcome of fetal cardiac intervention (FCI) in fetuses with critical aortic stenosis (CAS), severe mitral regurgitation (MR), severe left atrial dilatation (LAD), and restrictive foramen ovale (RFO) or intact atrial septum.

Methods: All fetuses with a prenatal diagnosis of CAS, severe MR, severe LAD, and RFO were retrospectively collected in one tertiary center for fetal medicine over a period of 10 years. Video recordings, pre- and postnatal charts were reviewed for cardiac and extracardiac anomalies, intrauterine course, and postnatal outcome. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000502840DOI Listing
October 2019
1 Read

Novel Trigone-Based Sizing Method for Mitral Ring Annuloplasty.

Ann Thorac Surg 2020 05 3;109(5):1385-1393. Epub 2019 Oct 3.

Department of Cardiovascular Surgery, Yokkaichi Municipal Hospital, Yokkaichi, Japan.

Background: We devised a novel trigone-based sizing method, setting the trigones at one-quarter of the annular circumference, and used it for mitral annuloplasty in patients with mitral regurgitation (MR).

Methods: Between 1999 and 2017, 436 patients with degenerative (n = 192), nonischemic functional (n = 124), or ischemic (n = 120) MR underwent mitral valvuloplasty at our institution using an incomplete ring. The intertrigonal distance and prerepair and postrepair annular diameter were measured. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2019.08.085DOI Listing
May 2020
1 Read

Balloon assisted translocation of the mitral anterior leaflet to prevent left ventricular outflow obstruction (BATMAN): A novel technique for patients undergoing transcatheter mitral valve replacement.

Catheter Cardiovasc Interv 2020 Mar 13;95(4):840-848. Epub 2019 Sep 13.

Center for Comprehensive Cardiovascular Care, Saint Louis University, Saint Louis, Missouri.

Introduction: Transcatheter mitral valve replacement (TMVR) is an option for patients at high risk for mitral valve replacement or repair via sternotomy or left thoracotomy approach. TMVR carries up to 22% risk of left ventricular outflow tract (LVOT) obstruction. Severe LVOT obstruction can have devastating hemodynamic and clinical consequences. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28496DOI Listing
March 2020
1 Read

Percutaneous venoarterial extracorporeal membrane oxygenation as a bridge to double valve implantation in acute biventricular heart failure with profound cardiogenic shock.

J Card Surg 2019 Dec 11;34(12):1664-1666. Epub 2019 Sep 11.

Advanced Critical Care, Nazih Zuhdi Transplant Institute, Advanced Cardiac Care and 24/7 Shock Service, Integris Baptist Medical Center, Oklahoma City, Oklahoma.

A 71-year-old woman was admitted with acute hypoxic and hypercapnic respiratory failure and cardiogenic shock, secondary to acute on chronic biventricular systolic and diastolic congestive heart failure and severe aortic and mitral valve stenosis. She further presented with pulmonary hypertension and moderate-to-severe tricuspid regurgitation requiring high and increasing doses of vasopressors. The patient was percutaneously cannulated for venoarterial extracorporeal membrane oxygenation (VA-ECMO) and stabilized on ECMO, with a urine output of 17. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jocs.14255DOI Listing
December 2019
3 Reads
0.888 Impact Factor

Predictors of Unfavourable Outcomes in Children and Adolescents Submitted to Surgical Mitral Valvuloplasty Secondary to Chronic Rheumatic Heart Disease.

Arq Bras Cardiol 2019 9;113(4):748-756. Epub 2019 Sep 9.

Escola Bahiana de Medicina e Saúde Pública, Salvador, BA - Brazil.

Background: Mitral valve repair in paediatric patients with chronic rheumatic heart disease is superior to valve replacement and has been used with good results.

Objective: To identify predictors of unfavourable outcomes in children and adolescents submitted to surgical mitral valvuloplasty secondary to rheumatic heart disease.

Methods: Retrospective study of 54 patients under the age of 16 operated at a tertiary paediatric hospital between March 2011 and January 2017. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5935/abc.20190184DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020859PMC
April 2020
4 Reads

The role of extracorporeal membrane oxygenation in an acute basal ventricular septal rupture.

Eur J Cardiothorac Surg 2020 Apr;57(4):799-800

Cardiothoracic Surgery Department, Hospital de Santa Cruz, Carnaxide, Lisbon, Portugal.

A 74-year-old man was admitted with a post-acute myocardial infarction basal ventricular septal rupture. Onset of cardiogenic shock led to the implantation of a percutaneous veno-arterial extracorporeal membrane oxygenation (ECMO) system with an additional venous drainage cannula into the right ventricle. The ventricular septal defect was repaired with concomitant tricuspid valvuloplasty and mitral bioprosthesis implantation after 14 days. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ejcts/ezz235DOI Listing
April 2020
3 Reads

Frugal innovation in the cardiac catheter laboratory: Retrograde balloon mitral valvuloplasty using extra back-up guide catheter.

J Cardiol Cases 2019 Sep 12;20(3):95-98. Epub 2019 Jul 12.

Department of Cardiology, Northeastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong, Meghalaya, India.

Conventional antegrade balloon mitral valvuloplasty is not possible or better avoided in certain clinical situations. Retrograde balloon mitral valvuloplasty is a purely arterial technique designed to avoid complications of atrial septal puncture. We report a case of rheumatic heart disease with severe mitral stenosis and large atrial septal aneurysm where balloon mitral valvuloplasty was performed retrogradely with innovative use of routinely available cardiac catheter laboratory hardware instead of specialised hardware required for such cases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jccase.2019.06.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718940PMC
September 2019
1 Read

Life-threatening hemoptysis following mitral valvuloplasty for rheumatic mitral stenosis.

Respir Med Case Rep 2019 13;28:100921. Epub 2019 Aug 13.

Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD, United States.

Background: Massive hemoptysis is a rare complication of rheumatic mitral valve stenosis. Its recurrence following successful initial treatment of the stenosis has not, to our knowledge, been described.

Case Report: We describe a 58-year-old African American woman with a history of balloon valvuloplasty for the treatment of severe rheumatic mitral valve stenosis who presented to our institution with massive life-threatening hemoptysis due to recurrent mitral valve stenosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmcr.2019.100921DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704374PMC
August 2019
2 Reads

Rapid ventricular pacing during transcatheter valve procedures using an internal device and programmer: A demonstration of feasibility.

Catheter Cardiovasc Interv 2020 Apr 20;95(5):1042-1048. Epub 2019 Aug 20.

Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.

Objectives: To develop a protocol for using a pre-existing, permanent pacemaker or defibrillator device for rapid ventricular pacing during transcatheter valve procedures and demonstrate feasibility.

Background: Placement of a passive fixation, temporary pacemaker wire is considered routine during most transcatheter valve procedures to facilitate controlled or rapid ventricular pacing at the time of balloon expansion or valve deployment. Many patients presenting for such procedures have a pre-existing, permanent pacemaker or defibrillator device which could be used for the same function, obviating the need for temporary pacemaker wire placement. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28450DOI Listing
April 2020
6 Reads

Study on the long-term curative effect of repeat percutaneous balloon mitral valvuloplasty in patients with mitral restenosis.

Medicine (Baltimore) 2019 Aug;98(32):e16790

To study the long-term curative effect of repeat percutaneous balloon mitral valvuloplasty (PBMV) in patients with mitral restenosis.In our study, mitral restenosis developed in 39 patients after PBMV. Repeat PBMV was performed according to the improved Inoue method. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000016790DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709142PMC
August 2019
2 Reads
5.723 Impact Factor

Survival analysis of patients with rheumatic MS after PBMV compared with MVS in a low-to-middle-income country.

Neth Heart J 2019 Nov;27(11):559-564

Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.

Introduction: Rheumatic mitral stenosis continues to be prevalent in developing countries, notably in endemic areas. Over the last few decades, percutaneous balloon mitral valvuloplasty (PBMV) has been established as a lower-cost alternative treatment for mitral stenosis (MS) in low-to-middle-income countries. PBMV has also been suggested to be an effective and safe alternative treatment modality. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12471-019-01315-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823404PMC
November 2019
2 Reads

Balloon Mitral Valvuloplasty in Mirror Image Dextrocardia with Rheumatic Mitral Stenosis with Suprasystemic Pulmonary Arterial Hypertension.

J Assoc Physicians India 2019 Apr;67(4):94-95

Physician, Intensivist, Poona Hospital, Pune, Maharashtra.

32 years old male with history of mirror image dextrocardia with situs inversus and history of rheumatic fever at age of 12 years on penicillin prophylaxis till 25 years of age presented with history of dyspnea on exertion NYHA class 2 since last five years. Cardiac colour Doppler 5 years back was suggestive of rheumatic mitral stenosis with mitral valve area 2 cm2 with mirror image dextrocardia with mild pulmonary arteriolar hypertension in normal sinus rhythm. Patient was put on medications and was advised regular follow up. Read More

View Article

Download full-text PDF

Source
April 2019
3 Reads

Commentary: Mitral valvuloplasty rings: Do they make the difference?

Authors:
Manuel J Antunes

J Thorac Cardiovasc Surg 2020 05 30;159(5):1775-1776. Epub 2019 May 30.

Faculty of Medicine, Clinic of Cardiothoracic Surgery, University of Coimbra, Coimbra, Portugal. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2019.05.022DOI Listing
May 2020
3 Reads

Percutaneous Mitral Balloon Valvuloplasty: Worldwide Trends.

Authors:
Igor F Palacios

J Am Heart Assoc 2019 07 29;8(13):e012898. Epub 2019 Jun 29.

1 Massachusetts General Hospital Boston MA.

See Article Desnos et al. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/JAHA.119.012898DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662352PMC
July 2019
2 Reads